Concepedia

Chris Dawe

CD

Statistics

Publications

5

Citations

191

H-Index

5

Active since

2004

Affiliations

St Mark's Hospital(Current)

Western General Hospital

Imperial College London

Barts Health NHS Trust

Newcastle upon Tyne Hospitals NHS Foundation Trust

Chris Dawe is an author at St Mark's Hospital specializing in life sciences, inflammatory bowel disease, and immunogenicity of biologic agents.

Publications per year

2004–2022

5

Publications

5

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

, , +17

Estimating flying-fox mortality associated with abandonments of pups and extreme heat events during the austral summer of 2019–20

Matthew Mo, Mike Roache, Janine M. Davies et al. · Pacific Conservation Biology · 2021 · 36 citations

, , +13

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

, , +17

Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: Correlation with genetic damage and cancer development

Martial Guillaud, Jean C. Le Riche, Chris Dawe et al. · Cytometry Part A · 2004 · 25 citations

, , +10

The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

Aurélien Amiot, Jean‐François Rahier, Filip Baert et al. · Journal of Crohn s and Colitis · 2022 · 14 citations · Full text

, , +10

1–5 of 5